We analyzed activated levels in tumor cells from EGFR-driven LUAD and found that only the activated form of NOTCH4 (NICD4) was greatly increased in tumor samples resistant to EGFR TKIs compared with those sensitive to EGFR TKIs. Here, NOTCH4 is linked to neoplasm.